Lichong Decoction represses colorectal cancer progression via inhibiting the PINK1/Parkin pathway regulated by Rab27B
Journal of Ethnopharmacology · 2025
DOI: 10.1016/j.jep.2025.119997 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Yu Dai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, 510315, Guangdon…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, rab GTP-Binding Proteins, Protein Kinases, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Guangdong Province Department of Education.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Lichong Decoction (LCD), a classical herbal formula, has been widely applied in clinical practice. Studies have validated its effectiveness in combating cancer; nevertheless, the exact pathways through which it influences colorectal cancer require further investigation. AIM OF THE STUDY: The mechanism of LCD in inhibiting colorectal cancer progression was investigated. MATERIALS AND METHODS: BALB/c-nu mice were xenografted with colorectal cancer cells to establish an animal model. The chemical constituents of LCD were characterised using high-performance liquid chromatography. Quantitative real-time PCR was employed to assess the expression levels of Rab27B mRNA. The Cancer Genome Atlas data of patients with colorectal cancer were used for gene clinical correlation analysis. Lentiviral transfection was used to construct stable cell lines. Cell motility was analysed using wound-healing and invasion assays. Pathological changes were observed using haematoxylin and eosin staining. Protein expression was determined using immunohistochemistry and western blotting. The results were statistically analysed using GraphPad Prism 10.1. 2. RESULTS: In vivo, LCD treatment led to a substantial decrease in the size of colorectal cancer tumours. Importantly, LCD markedly lowered the expression of Rab27B and proteins related to the PINK1/Parkin pathway in tumour tissues. In vitro, LCD significantly reduced the expression of Rab27B in colorectal cancer cells. Consistent with the results in vivo, the reduction in Rab27B inhibited PINK1/Parkin signalling protein expression and prevented the migration and invasion of colorectal cancer cells. CONCLUSIONS: Lichong Decoction inhibits colorectal cancer growth by dampening PINK1/Parkin signalling in colorectal cancer cells through repressing Rab27B.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, 510315, Guangdong, China. Electronic address: dy_smu@126.com.
- Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, 510315, Guangdong, China. Electronic address: lifei19@smu.edu.cn.
- Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, 510315, Guangdong, China. Electronic address: tangyao0626@126.com.
- Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, 510315, Guangdong, China. Electronic address: sll_smu@126.com.
- Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, 510315, Guangdong, China. Electronic address: lyp_smu@sina.com.
- School of Traditional Chinese Medicine, Department of Traditional Chinese Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. Electronic address: zjy_smu@126.com.
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangdong Province Department of Education
Zitieren
APA
Dai, Y., Li, F., Tang, Y., Sun, L., Liu, Y., Zhan, J., Zhou, C., & Li, A. (2025). Lichong Decoction represses colorectal cancer progression via inhibiting the PINK1/Parkin pathway regulated by Rab27B. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119997
Vancouver
Dai Y, Li F, Tang Y, Sun L, Liu Y, Zhan J, et al. Lichong Decoction represses colorectal cancer progression via inhibiting the PINK1/Parkin pathway regulated by Rab27B. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119997
BibTeX
@article{Dai2025,
author = {Dai, Yu and Li, Fei and Tang, Yao and Sun, Lingling and Liu, Yongpu and Zhan, Jinyan and Zhou, Chuying and Li, Aimin},
title = {Lichong Decoction represses colorectal cancer progression via inhibiting the PINK1/Parkin pathway regulated by Rab27B},
journal = {Journal of Ethnopharmacology},
year = {2025},
doi = {10.1016/j.jep.2025.119997}
}
EUVIMED